Home
Storia in 1 fonti
Agios licenses Oscotec drug; CEPI funds three potential Ebola vaccines
Agios licenses Oscotec’s immune thrombocytopenia drug; CEPI funds three Ebola vaccine candidates; Skyhawk shares Huntington's data;
Raccontata da
endpoints.news
Timeline cronologica
- ·
AstraZeneca seeks path for failed antibody; Imfinzi, Tremfya get label expansions
AstraZeneca seeks a narrower path for failed antibody; Imfinzi and Tremfya label expansions
- ·
Agios licenses Oscotec drug; CEPI funds three potential Ebola vaccines
Agios licenses Oscotec’s immune thrombocytopenia drug; CEPI funds three Ebola vaccine candidates; Skyhawk shares Huntington's data;